163 related articles for article (PubMed ID: 31298379)
1. Study on diagnostic value of P1NP and β-CTX in bone metastasis of patients with breast cancer and the correlation between them.
Zuo CT; Yin DC; Fan HX; Lin M; Meng Z; Xin GW; Zhang YC; Cheng L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5277-5284. PubMed ID: 31298379
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer.
Dean-Colomb W; Hess KR; Young E; Gornet TG; Handy BC; Moulder SL; Ibrahim N; Pusztai L; Booser D; Valero V; Hortobagyi GN; Esteva FJ
Breast Cancer Res Treat; 2013 Jan; 137(2):631-6. PubMed ID: 23242617
[TBL] [Abstract][Full Text] [Related]
3. A dual-label time-resolved fluorescence immunoassay for screening of osteoporosis based on simultaneous detection of C-terminal telopeptide (β-CTX) and aminoterminal propeptide (P1NP) of type I procollagen.
Xu Y; Wang Q; Hou G; Yao H; Zhao H
Scand J Clin Lab Invest; 2019; 79(1-2):80-85. PubMed ID: 30638079
[TBL] [Abstract][Full Text] [Related]
4. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
5. Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors.
Zhao H; Han KL; Wang ZY; Chen Y; Li HT; Zeng JL; Shen Z; Yao Y
Med Sci Monit; 2011 Nov; 17(11):CR626-633. PubMed ID: 22037741
[TBL] [Abstract][Full Text] [Related]
6. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of serum total P1NP, β-CTX and 25(OH)D3 detection in evaluating risks of fragile hip fracture in elderly patients with osteoporosis].
Lou H; Peng C; Chen Q
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1346-9. PubMed ID: 22985580
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy.
Alonso S; Ferrero E; Donat M; Martínez G; Vargas C; Hidalgo M; Moreno E
J Endocrinol Invest; 2012 Jul; 35(7):640-4. PubMed ID: 21946027
[TBL] [Abstract][Full Text] [Related]
9. Study of the distribution by age group of serum cross-linked C-terminal telopeptide of type I collagen and procollagen type I N-propeptide in healthy Japanese women to establish reference values.
Nomura Y; Yoshizaki A; Yoshikata H; Kikuchi R; Sakakibara H; Chaki O; Fukunaga M; Hirahara F
J Bone Miner Metab; 2013 Nov; 31(6):644-51. PubMed ID: 23579312
[TBL] [Abstract][Full Text] [Related]
10. Serum 25(OH)D is associated with an altered bone turnover marker response after a hip fracture.
Stewart CC; O'Hara NN; Orwig D; Hochberg MC; Sprague S; Magaziner J; Slobogean GP
J Orthop Res; 2019 Mar; 37(3):535-540. PubMed ID: 30578572
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and its relationship with markers of bone metabolism in healthy Asian women.
Tan KM; Saw S; Sethi SK
J Clin Lab Anal; 2013 Jul; 27(4):301-4. PubMed ID: 23852789
[TBL] [Abstract][Full Text] [Related]
12. Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial.
Brown J; Rathbone E; Hinsley S; Gregory W; Gossiel F; Marshall H; Burkinshaw R; Shulver H; Thandar H; Bertelli G; Maccon K; Bowman A; Hanby A; Bell R; Cameron D; Coleman R
J Natl Cancer Inst; 2018 Aug; 110(8):871-879. PubMed ID: 29425304
[TBL] [Abstract][Full Text] [Related]
13. Thalassemic osteopathy: a new marker of bone deposition.
Baldini M; Forti S; Orsatti A; Marcon A; Ulivieri FM; Airaghi L; Zanaboni L; Cappellini MD
Blood Cells Mol Dis; 2014; 52(2-3):91-4. PubMed ID: 24091145
[TBL] [Abstract][Full Text] [Related]
14. Application of Bone Turnover Markers PICP and β-CTx in the Diagnosis and Treatment of Breast Cancer with Bone Metastases.
Song B; Li X; Zhou Q; Yang X; Jiang Y; Wang A
Clin Lab; 2018 Jan; 64(1):11-16. PubMed ID: 29479886
[TBL] [Abstract][Full Text] [Related]
15. Bone turnover markers in Spanish adult men The Camargo Cohort Study.
Olmos JM; Hernández JL; Martínez J; Pariente E; Llorca J; González-Macías J
Clin Chim Acta; 2010 Oct; 411(19-20):1511-5. PubMed ID: 20594548
[TBL] [Abstract][Full Text] [Related]
16. The Relevance of Osteoclastic and Osteoblastic Activity Markers Follow-Up in Patients on Antiresorptive Osteoporosis Treatment.
Smilic TN; Novakovic TR; Markovic-Jovanovic SR; Smilic LLJ; Mitic JS; Radunovic ML
J Clin Densitom; 2018; 21(3):322-328. PubMed ID: 29103946
[TBL] [Abstract][Full Text] [Related]
17. Novel serological biomarker models composed of bone turnover markers, vitamin D, and estradiol and their auxiliary diagnostic value in girls with idiopathic central precocious puberty.
Zhang J; Gao R; Jiang Y; Zhang Y; Liu C; Yu F; Zhou W
Bone; 2022 Jan; 154():116221. PubMed ID: 34600161
[TBL] [Abstract][Full Text] [Related]
18. Association of Insulin Resistance and β-cell Function With Bone Turnover Biomarkers in Dysglycemia Patients.
Guo H; Wang C; Jiang B; Ge S; Cai J; Zhou Y; Ying R; Zha K; Zhou J; Wang N; Zhu C; Cao C; Zhang L; Gu T; Zhao Y; Lu Y; An Z
Front Endocrinol (Lausanne); 2021; 12():554604. PubMed ID: 33841321
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.
Jørgensen NR; Møllehave LT; Hansen YBL; Quardon N; Lylloff L; Linneberg A
Osteoporos Int; 2017 Jul; 28(7):2103-2113. PubMed ID: 28455749
[TBL] [Abstract][Full Text] [Related]
20. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas.
Oremek G; Sauer-Eppel H; Klepzig M
Anticancer Res; 2007; 27(4A):1961-2. PubMed ID: 17649805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
